Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

ClinicalTrials.gov ID: NCT01555164

Public ClinicalTrials.gov record NCT01555164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 1:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Metformin in Subjects With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to determine the effect of ranolazine when added to metformin on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable metformin therapy in addition to diet and exercise.

Study identification

NCT ID
NCT01555164
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
442 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2012 (Type not available)
Primary completion
Sep 2013 (Actual)
Completion
Oct 2013 (Actual)
Last update posted
Sep 23, 2014

2012 – 2013

United States locations

U.S. sites
60
U.S. states
24
U.S. cities
56
Facility City State ZIP Site status
Fundamental Research LLC Gulf Shores Alabama 36542 —
KLR Business Group DBA Arkansas Clinical Research Little Rock Alaska 72205 —
Radiant Research, Inc. Chandler Arizona 85224 —
Central Phoenix Medical Clinic Phoenix Arizona 85020 —
Clinical Research Advantage Tempe Arizona 85282 —
Desert Sun Clinical Research, LLC Tucson Arizona 85710 —
National Research Institute Los Angeles California 90057 —
Ritchken and First MD's San Diego California 92117 —
Clearview Medical Research, LLC Santa Clarita California 91350 —
Metabolic Institute of America Tarzana California 91356 —
University Clinical Investigators Tustin California 92780 —
Infosphere Clinical Research West Hills California 91307 —
Colorado Springs Health Partners Colorado Springs Colorado 80906 —
Boca Raton Clinical Research Associates, Inc. Boca Raton Florida 33432 —
MD Clinical Institute Hallandale Florida 33009 —
A G A Clinical Trials Hialeah Florida 33012 —
Baptist Diabetes Associates Miami Florida 33156 —
Florida Institute for Clinical Research LLC Orlando Florida 32822 —
Medical Research Group of Central Florida Sanford Florida 32771 —
Synergy Therapeutic Partners Atlanta Georgia 30312 —
Perimeter Institute for Clinical Research Atlanta Georgia 30338 —
Columbus Research Foundation Columbus Georgia 31904 —
Advanced Clinical Research Boise Idaho 83642 —
Choose To Lose Eagle Idaho 83616 —
Cedar-Crosse Research Center Chicago Illinois 60607 —
Alexandria Cardiology Clinic Alexandria Louisiana 71301 —
Covington Medical Care Mandeville Louisiana 70471 —
Clinical Trials Management, LLC Metairie Louisiana 70006 —
MD Medical Research Oxon Hill Maryland 20745 —
Bellevue Family Practice Bellevue Nebraska 68005 —
Clinical Research Advantage Henderson Nevada 89052 —
Albuquerque Clinical Trials, Inc. Albuquerque New Mexico 87102 —
University of New Mexico Health Sciences Center Albuquerque New Mexico 87131-0001 —
PhysiqueMed Clinical Trials Greensboro North Carolina 27405 —
Clinical Trials of America Inc Hickory North Carolina 28601 —
University Medical Associates Huntersville North Carolina 28078 —
Northstate Clinical Research Lenoir North Carolina 28645 —
Carolina Research Center Shelby North Carolina 28150 —
Lillestol Research Fargo North Dakota 58103 —
Rapid Medical Research, Inc Cleveland Ohio 44122 —
Columbus Clinical Research Inc. Columbus Ohio 43213 —
Hometown Urgent Care and Research Dayton Ohio 45432 —
Blair Medical Associates Inc. Altoona Pennsylvania 16602 —
Safe Harbor Clinical Research East Providence Rhode Island 02914 —
Pharmacorp Clinical Trials, Inc. Charleston South Carolina 29412 —
DeGarmo Institute of Medical Research Greer South Carolina 29651 —
Holston Medical Group, P.C. Bristol Tennessee 37620 —
New Phase Research & Development Knoxville Tennessee 37923 —
Not listed Corpus Christi Texas 78414 —
Dallas Diabetes and Endocrine Center Dallas Texas 75230 —
West Houston Clinical Research Houston Texas 77055 —
Juno Research, LLC Houston Texas 77074 —
Texas Center for Drug Development, Inc. Houston Texas 77081 —
Juno Research, LLC Katy Texas 77450 —
Northeast Clinical Research of San Antonio, LLC Schertz Texas 78154 —
Not listed Sugarland Texas 77479 —
Progressive Clinical Research, LLC Bountiful Utah 84010 —
Highland Clinical Research Salt Lake City Utah 84124 —
Burke Internal Medicine, Inc. Burke Virginia 22015 —
Manassas Clinical Research Center Manassas Virginia 20110 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01555164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2014 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01555164 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →